With mucin concentrations 5–10 fold higher in CF sputum than that of healthy alternatives, there is the potential for CF sputum to be a driving force for in vivo resistance10,11; a factor which is rarely considered during in vitro drug screening. The gene discussed is MUC5AC; the disease is cystic fibrosis.